期刊文献+

非核苷类HIV逆转录酶抑制剂的专利技术研究进展

Research Progress of Patent Technology on Non-nucleoside HIV Reverse Transcriptase Inhibitor
下载PDF
导出
摘要 HIV逆转录酶抑制剂是治疗HIV药物研究的热点,尤其是非核苷类逆转录酶抑制剂的开发更是近年来令人瞩目的焦点。文章就近十年来新合成的非核苷类HIV逆转录酶抑制剂的中国专利技术进行综述,为HIV逆转录酶抑制剂药物的研发设计提供参考。 Since the HIV reverse transcriptase inhibitor has become one of the research hotspots in the development of HIV drugs, especially the development of non-nucleoside reverse transcriptase inhibitors has been the focus of attention in recent years, the paper overviews the Chinese patent technology of the newly synthesized non-nucleoside HIV reverse transcriptase inhibitors (NNRTIs) in the past ten years, and provides references for the design and development of HIV reverse transcriptase inhibitor drugs.
作者 金英 Jin Ying(Patent Examination Cooperation Center of the Patent Office SIPO Beijing, Beijing 100081, China)
出处 《广东化工》 CAS 2019年第19期124-126,共3页 Guangdong Chemical Industry
关键词 HIV逆转录酶 抑制剂 非核苷 HIV reverse transcriptase inhibitor non-nucleoside
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部